Manuel Beltran

ORCID: 0000-0001-8585-4790
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lymphoma Diagnosis and Treatment
  • Cutaneous lymphoproliferative disorders research
  • Chronic Lymphocytic Leukemia Research
  • T-cell and Retrovirus Studies
  • Bacterial Infections and Vaccines
  • CNS Lymphoma Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Long-Term Effects of COVID-19
  • Healthcare cost, quality, practices
  • Cardiac, Anesthesia and Surgical Outcomes
  • Bladder and Urothelial Cancer Treatments
  • Eosinophilic Esophagitis
  • Health Systems, Economic Evaluations, Quality of Life
  • Radiation Therapy and Dosimetry
  • Occupational and environmental lung diseases
  • Pneumonia and Respiratory Infections
  • Head and Neck Cancer Studies
  • Renal and related cancers
  • Fungal Infections and Studies
  • Effects of Radiation Exposure
  • Eosinophilic Disorders and Syndromes
  • Monoclonal and Polyclonal Antibodies Research
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Renal cell carcinoma treatment
  • Viral-associated cancers and disorders

St. Barnabas Hospital
2021-2023

City University of New York
2023

WinnMed
2019-2021

Mayo Clinic in Florida
2019-2020

Hospital Universitario Puerta del Mar
2001-2019

Summary Background The malignant mechanisms that control the development of cutaneous T-cell lymphoma (CTCL) are beginning to be identified. Recent evidence suggests disturbances in specific intracellular signalling pathways, such as RAS–mitogen-activated protein kinase, receptor (TCR)–phospholipase C gamma 1 (PLCG1)–nuclear factor activated T cells (NFAT) and Janus kinase (JAK)–signal transducer activator transcription (STAT), may play an essential role pathogenesis CTCL. Objectives To...

10.1111/bjd.18098 article EN British Journal of Dermatology 2019-05-03

Myopodin is a cytoskeleton protein that shuttles to the nucleus depending on cellular differentiation and stress. It has shown tumor suppressor functions. methylation status was useful for staging bladder colon tumors predicting clinical outcome. To our knowledge, myopodin not been tested in kidney cancer date. The purpose of this study evaluate whether could be clinically renal (1) as prognostic biomarker 2) predictive factor response antiangiogenic therapy patients with metastatic disease....

10.1007/s13277-016-5267-8 article EN Tumor Biology 2016-09-03

Cutaneous involvement by precursor T-cell lymphoblastic leukemia/lymphoma (T-ALL/LBL) is rare, and almost all cases are seen in association with bone marrow, blood, and/or lymph node involvement. Presentation isolated skin very rare. Literature review revealed only one case report of primary cutaneous LBL. We discuss here another patient diagnosed LBL at our institute. This was initially misdiagnosed as having peripheral lymphoma NOS. Cytogenetic analysis showed the CDKN2A deletion (-9p21×2)...

10.1155/2019/3540487 article EN cc-by Case Reports in Hematology 2019-02-20

Crystal-storing histiocytosis (CSH) is an uncommon condition in which histiocytes accumulate a crystalline matter within their cytoplasm. Generally, those crystals are composed of either monoclonal or polyclonal immunoglobulin chains, have strong association with underlying lymphoproliferative plasma cell disorder (LP-PCD). Rarely, CSH has been reported as local generalized manifestation variety benign disorders. These cases associated nonimmunoglobulin substances. We reporting exceptional...

10.1155/2020/8856411 article EN cc-by Case Reports in Hematology 2020-10-19

This case report presents a 53-year-old male patient infected with COVID-19 who developed acute respiratory distress syndrome (ARDS) and septic shock due to meningococcemia, despite the absence of clinical signs meningitis. patient's condition was complicated by pneumonia in setting myocardial failure. In curse disease, it is remarked that importance early recognition sepsis symptoms crucial distinguishing patients from those other infections preventing fatal outcomes. The presented an...

10.7759/cureus.39713 article EN Cureus 2023-05-30
Coming Soon ...